Evidence-informed management of chronic low back pain with adjunctive analgesics

被引:13
作者
Chang, Victor [1 ,2 ]
Gonzalez, Peter [1 ,2 ]
Akuthota, Venu [1 ,2 ]
机构
[1] Univ Colorado Hosp, Spine Ctr, Boulder, CO USA
[2] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Boulder, CO 80309 USA
关键词
chronic low back pain; socioeconomic; nonsurgical therapies; neuropathic medications;
D O I
10.1016/j.spinee.2007.10.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EDITORS' PREFACE: The management of chronic low back pain (CLBP) has proven very challenging in North America, as evidenced by its mounting socioeconomic burden. Choosing among available nonsurgical therapies can be overwhelming for many stakeholders, including patients, health providers, policy makers, and third-party payers. Although all parties share a common goal and wish to use limited health-care resources to support interventions most likely to result in clinically meaningful improvements, there is often uncertainty about the most appropriate intervention for a particular patient. To help understand and evaluate the various commonly used nonsurgical approaches to CLBP, the North American Spine Society has sponsored this special focus issue of The Spine Journal, titled Evidence-Informed Management of Chronic Low Back Pain Without Surgery. Articles in this special focus issue were contributed by leading spine practitioners and researchers, who were invited to summarize the best available evidence for a particular intervention and encouraged to make this information accessible to nonexperts. Each of the articles contains five sections (description, theory, evidence of efficacy, harms, and summary) with common subheadings to facilitate comparison across the 24 different interventions profiled in this special focus issue, blending narrative and systematic review methodology as deemed appropriate by the authors. It is hoped that articles in this special focus issue will be informative and aid in decision making for the many stakeholders evaluating nonsurgical interventions for CLBP. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 45 条
[1]
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[2]
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors [J].
Bymaster, FP ;
Dreshfield-Ahmad, LJ ;
Threlkeld, PG ;
Shaw, JL ;
Thompson, L ;
Nelson, DL ;
Hemrick-Luecke, SK ;
Wong, DT .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (06) :871-880
[3]
Rationale and evidence for the use of oxcarbazepine in neuropathic pain [J].
Carrazana, E ;
Mikoshiba, I .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (05) :S31-S35
[4]
Gabapentin vs. amitriptyline in painful diabetic neuropathy: An open-label pilot study [J].
Dallocchio, C ;
Buffa, C ;
Mazzarello, P ;
Chiroli, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (04) :280-285
[5]
Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression [J].
Detke, MJ ;
Lu, YL ;
Goldstein, DJ ;
McNamara, RK ;
Demitrack, MA .
JOURNAL OF PSYCHIATRIC RESEARCH, 2002, 36 (06) :383-390
[6]
Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial [J].
Detke, MJ ;
Lu, YL ;
Goldstein, DJ ;
Hayes, JR ;
Demitrack, MA .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (04) :308-315
[7]
Advances in neuropathic pain - Diagnosis, mechanisms, and treatment recommendations [J].
Dworkin, RH ;
Backonja, M ;
Rowbotham, MC ;
Allen, RR ;
Argoff, CR ;
Bennett, GJ ;
Bushnell, MC ;
Farrar, JT ;
Galer, BS ;
Haythornthwaite, JA ;
Hewitt, DJ ;
Loeser, JD ;
Max, MB ;
Saltarelli, M ;
Schmader, KE ;
Stein, C ;
Thompson, D ;
Turk, DC ;
Wallace, MS ;
Watkins, LR ;
Weinstein, SM .
ARCHIVES OF NEUROLOGY, 2003, 60 (11) :1524-1534
[8]
Lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia [J].
Eisenberg, E ;
Damunni, G ;
Hoffer, E ;
Baum, Y ;
Krivoy, N .
EUROPEAN JOURNAL OF PAIN, 2003, 7 (06) :485-491
[9]
Lamotrigine reduces painful diabetic neuropathy - A randomized, controlled study [J].
Eisenberg, E ;
Lurie, Y ;
Braker, C ;
Daoud, D ;
Ishay, A .
NEUROLOGY, 2001, 57 (03) :505-509
[10]
Algorithm for neuropathic pain treatment: An evidence based proposal [J].
Finnerup, NB ;
Otto, M ;
McQuay, HJ ;
Jensen, TS ;
Sindrup, SH .
PAIN, 2005, 118 (03) :289-305